Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2005 1
2006 2
2007 2
2009 5
2010 4
2011 8
2012 5
2013 5
2014 8
2015 4
2016 1
2017 1
2018 2
2019 2
2020 3
2021 4
2022 3
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

53 results

Results by year

Filters applied: . Clear all
Page 1
Contactin-associated protein 2 autoantibodies can be associated with multifocal motor-like neuropathy: a case report.
Müller-Miny L, Sauer R, Schulte-Mecklenbeck A, Gross CC, Kovac S, Schilling M, Beuker C, Wiendl H, Meyer Zu Hörste G. Müller-Miny L, et al. Among authors: schilling m. Ther Adv Neurol Disord. 2023 Aug 16;16:17562864231189323. doi: 10.1177/17562864231189323. eCollection 2023. Ther Adv Neurol Disord. 2023. PMID: 37599705 Free PMC article.
Surfing the waves of the COVID-19 pandemic with diabetes mellitus: Analysis of changes in the diabetes therapy, metabolism and physical activity of 92 992 people living with type 1 or type 2 diabetes from the German DPV registry.
Hartmann B, Tittel SR, Gillesen A, Klarl B, Kopp F, Meyhöfer S, Naudorf M, Schilling M, Wosch FJ, Holl RW; DPV Initiative. Hartmann B, et al. Among authors: schilling m. Diabetes Obes Metab. 2023 Sep;25(9):2774-2779. doi: 10.1111/dom.15149. Epub 2023 May 31. Diabetes Obes Metab. 2023. PMID: 37254679 No abstract available.
Endovascular stroke therapy outside core working hours in a nationwide stroke system.
Fandler-Höfler S, Mikšová D, Deutschmann H, Kneihsl M, Mutzenbach S, Killer-Oberpfalzer M, Gizewski ER, Knoflach M, Kiechl S, Sonnberger M, Vosko MR, Weber J, Hausegger KA, Serles W, Werner P, Staykov D, Sykora M, Lang W, Ferrari J, Enzinger C, Gattringer T; Austrian EVT Study Group. Fandler-Höfler S, et al. J Neurointerv Surg. 2023 Dec 21;15(e3):e402-e408. doi: 10.1136/jnis-2022-020044. J Neurointerv Surg. 2023. PMID: 36813552
Patisiran treatment in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy after liver transplantation.
Schmidt HH, Wixner J, Planté-Bordeneuve V, Muñoz-Beamud F, Lladó L, Gillmore JD, Mazzeo A, Li X, Arum S, Jay PY, Adams D; Patisiran Post-LT Study Group. Schmidt HH, et al. Am J Transplant. 2022 Jun;22(6):1646-1657. doi: 10.1111/ajt.17009. Epub 2022 Mar 26. Am J Transplant. 2022. PMID: 35213769 Free PMC article. Clinical Trial.
Detecting myasthenia gravis as a cause of unclear dysphagia with an endoscopic tensilon test.
Warnecke T, Im S, Labeit B, Zwolinskaya O, Suntrup-Krüger S, Oelenberg S, Ahring S, Schilling M, Meuth S, Melzer N, Wiendl H, Ruck T, Dziewas R. Warnecke T, et al. Among authors: schilling m. Ther Adv Neurol Disord. 2021 Aug 11;14:17562864211035544. doi: 10.1177/17562864211035544. eCollection 2021. Ther Adv Neurol Disord. 2021. PMID: 34394727 Free PMC article.
Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study.
Adams D, Polydefkis M, González-Duarte A, Wixner J, Kristen AV, Schmidt HH, Berk JL, Losada López IA, Dispenzieri A, Quan D, Conceição IM, Slama MS, Gillmore JD, Kyriakides T, Ajroud-Driss S, Waddington-Cruz M, Mezei MM, Planté-Bordeneuve V, Attarian S, Mauricio E, Brannagan TH 3rd, Ueda M, Aldinc E, Wang JJ, White MT, Vest J, Berber E, Sweetser MT, Coelho T; patisiran Global OLE study group. Adams D, et al. Lancet Neurol. 2021 Jan;20(1):49-59. doi: 10.1016/S1474-4422(20)30368-9. Epub 2020 Nov 16. Lancet Neurol. 2021. PMID: 33212063 Clinical Trial.
53 results